medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2018-3-22-25medsovet-2449Research ArticleЗАБОЛЕВАНИЯ ПИЩЕВОДА И ЖЕЛУДКАESOPHAGEAL AND GASTRIC DISEASESАлгоритм лечения больных функциональной диспепсией с позиций современных клинических рекомендацийTreatment algorithm for patients with functional dyspepsia from the perspective of current clinical guidelinesАндреевД. Н.AndreevD. N.

к.м.н.

PhD in medicine

Московский государственный медико-стоматологический университет им. А.И. Евдокимова Минздрава РоссииРоссияYevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of RussiaRussian Federation201819042018032225Copyright © Андреев Д.Н., 20182018Андреев Д.Н.Andreev D.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/2449

В статье представлен современный алгоритм лечения пациентов с функциональной диспепсией, основанный на клинических рекомендациях Римского консенсуса IV пересмотра (2016 г.), Российской гастроэнтерологической ассоциации (2017 г.), а также Американской и Канадской коллегии гастроэнтерологов (2017 г.). Оцениваются возможности эрадикации инфекции Helicobacter pylori как одного из этапов ведения пациентов с этой функциональной патологией. Рассматривается стратегия дифференцированного применения ингибиторов протонной помпы и прокинетиков при различных вариантах функциональной диспепсии.

 

The article presents a current algorithm for treating patients with functional dyspepsia, which is based on the clinical guidelines of the Rome IV Revision (2016), the Russian Gastroenterological Association (2017), and the American and Canadian Associations of Gastroenterologists (2017). It provides evaluation of the options for eradication of Helicobacter pylori infection as one of the stages of management of patients with this functional disorder. It also discusses the strategy for differentiated use of proton pump inhibitors and prokinetics for various variants of functional dyspepsia.

функциональные заболеванияфункциональная диспепсияРимские критерии IV пересмотраингибиторы протонной помпыпрокинетикиHelicobacter pyloriэрадикацияfunctional diseasesfunctional dyspepsiaRoman IV revision criteriaproton pump inhibitorsprokineticsHelicobacter pylorieradicationReferencesАндреев Д.Н., Заборовский А.В., Трухманов А.С. и др. Эволюция представлений о функциональных заболеваниях желудочно-кишечного тракта в свете Римских критериев IV пересмотра (2016 г.). РЖГГК, 2017, 1: 4-11Andreev DN, Zaborovsky AV, Trukhmanov AS et al. Evolution of ideas about functional diseases of the gastrointestinal tract in the light of the Rome IV criteria (2016). RJGGK, 2017, 1: 4-11.Маев И.В., Кучерявый Ю.А., Андреев Д.Н. Функциональная диспепсия: эпидемиология, классификация, этиопатогенез, диагностика и лечение: научное досье. М.: ООО «СТ-Принт», 2015Maev IV, Kucheryavy Yu.A., Andreev DN. Functional dyspepsia: epidemiology, classification, etiopathogenesis, diagnosis and treatment: scientific dossier. M.: ST-Print LLC, 2015.Tack J. Dyspepsia. In: Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 10th ed. Philadelphia, Pa: Saunders Elsevier, 2015: chap 14.Tack J. Dyspepsia. In: Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 10th ed. Philadelphia, Pa: Saunders Elsevier, 2015: chap 14.Agreus L. Natural history of dyspepsia. Gut, 2002, 50(Suppl 4): iv2–iv9.Agreus L. Natural history of dyspepsia. Gut, 2002, 50(Suppl 4): iv2–iv9.El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment. Pharmacol. Ther., 2004, 19: 643–654.El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment. Pharmacol. Ther., 2004, 19: 643–654.Mahadeva S, Ford AC. Clinical and epidemiological differences in functional dyspepsia between the East and the West. Neurogastroenterol Motil, 2016, 28(2): 167-74.Mahadeva S, Ford AC. Clinical and epidemiological differences in functional dyspepsia between the East and the West. Neurogastroenterol Motil, 2016, 28(2): 167-74.Маев И.В., Андреев Д.Н., Дичева Д.Т. и др. Функциональная диспепсия: современное состояние проблемы. Медицинский вестник МВД, 2013, 4: 38-45Maev IV, Andreev DN, Dicheva DT, et al. Functional dyspepsia: the current state of the problem. Medicinskij Vestnik MVD, 2013, 4: 38-45.Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, Tack J, Talley NJ. Gastroduodenal Disorders. Gastroenterology, 2016, 150(6): 1380-92.Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, Tack J, Talley NJ. Gastroduodenal Disorders. Gastroenterology, 2016, 150(6): 1380-92.Маев И.В., Дичева Д.Т., Щегланова М.П. и др. Функциональная диспепсия в свете Римских критериев IV пересмотра (2016 г.). Гастроэнтерология. Приложение к журналу Consilium Medicum, 2016, 2: 5-10Maev IV, Dicheva DT, Scheglanova MP. Functional dyspepsia in the light of the Rome IV criteria (2016). Gastroenterologiya. Prilozhenie k zhurnalu Consilium Medicum, 2016, 2: 5-10.Drossman DA. Functional Gastrointestinal Dis orders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology, 2016, 150: 1262–1279.Drossman DA. Functional Gastrointestinal Dis orders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology, 2016, 150: 1262–1279.Moayyedi PM, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N. ACG and CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol, 2017, 112(7): 988-1013.Moayyedi PM, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N. ACG and CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol, 2017, 112(7): 988-1013.Ивашкин В.Т., Маев И.В., Шептулин А.А. и др. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению функциональной диспепсии. РЖГГК, 2017, 1: 50–61.Ivashkin VT, Maev IV, Sheptulin AA et al. Clinical recommendations of the Russian gastroenterological association for the diagnosis and treatment of functional dyspepsia. RJGGK, 2017, 1: 50-61.Кучерявый Ю.А., Андреев Д.Н. Функциональная диспепсия: современный алгоритм терапии и реалии российской практики. Гастроэнтерология. Приложение к журналу Consilium Medicum, 2014, 1: 27-32Kucheryavy YA, Andreev DN. Functional dyspepsia: a modern algorithm of therapy and the realities of Russian practice. Gastroenterologiya. Prilozhenie k zhurnalu Consilium Medicum, 2014, 1: 27-32.Sugano K, Tack J, Kuipers EJ et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut, 2015, 64(9): 1353-67.Sugano K, Tack J, Kuipers EJ et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut, 2015, 64(9): 1353-67.Malfertheiner P, Megraud F, O’Morain CA et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut, 2017, 66(1): 6-30.Malfertheiner P, Megraud F, O’Morain CA et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut, 2017, 66(1): 6-30.Moayyedi P, Soo S, Deeks J et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev, 2005, 2: CD002096.Moayyedi P, Soo S, Deeks J et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev, 2005, 2: CD002096.Zhao B, Zhao J, Cheng WF, Shi WJ, Liu W, Pan XL, Zhang GX. Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up. J Clin Gastroenterol, 2014, 48: 241–247.Zhao B, Zhao J, Cheng WF, Shi WJ, Liu W, Pan XL, Zhang GX. Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up. J Clin Gastroenterol, 2014, 48: 241–247.Du L.J., Chen BR, Kim JJ et al. Helicobacter pylori eradication therapy for functional dyspepsia: Systematic review and meta-analysis. World J Gastroenterol, 2016, 22(12): 3486-95.Du L.J., Chen BR, Kim JJ et al. Helicobacter pylori eradication therapy for functional dyspepsia: Systematic review and meta-analysis. World J Gastroenterol, 2016, 22(12): 3486-95.Маев И.В., Самсонов А.А., Андреев Д.Н., Кочетов С.А. Дифференцированная тактика лечения синдрома функциональной диспепсии. Медицинский совет, 2012, 9: 13-20Maev IV, Samsonov AA, Andreev DN, Kochetov SA. Differentiated tactics of treatment of functional dyspepsia syndrome. Meditsinskiy sovet, 2012, 9: 13-20Маев И.В., Самсонов А.А., Андреев Д.Н. Инфекция Helicobacter pylori. М.: ГЭОТАР-Медиа, 2016.Maev IV, Samsonov AA, Andreev DN. Helico bacter pylori Infection. Moscow: GEOTAR-Media, 2016.Wang WH, Huang JQ, Zheng GF et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled tri als. Clin Gastroenterol Hepatol, 2007, 5(2): 178-185.Wang WH, Huang JQ, Zheng GF et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled tri als. Clin Gastroenterol Hepatol, 2007, 5(2): 178-185.Pinto-Sanchez MI, Yuan Y, Bercik P, Moayyedi P. Proton pump inhibitors for functional dyspepsia. Cochrane Database Syst Rev. 2017, 3: CD011194.Pinto-Sanchez MI, Yuan Y, Bercik P, Moayyedi P. Proton pump inhibitors for functional dyspepsia. Cochrane Database Syst Rev. 2017, 3: CD011194.Sychev DA, Denisenko NP, Sizova ZM, Grachev AV, Velikolug KA. The frequency of CYP2C19 genetic polymorphisms in Russian patients with peptic ulcers treated with proton pump inhibitors. Pharmgenomics Pers Med, 2015, 8: 111-4.Sychev DA, Denisenko NP, Sizova ZM, Grachev AV, Velikolug KA. The frequency of CYP2C19 genetic polymorphisms in Russian patients with peptic ulcers treated with proton pump inhibitors. Pharmgenomics Pers Med, 2015, 8: 111-4.Moayyedi P, Soo S, Deeks J et al. Pharmaco logical interventions for non-ulcer dyspepsia. Cochrane Database Syst. Rev., 2006, (4): CD001960.Moayyedi P, Soo S, Deeks J et al. Pharmaco logical interventions for non-ulcer dyspepsia. Cochrane Database Syst. Rev., 2006, (4): CD001960.Маев И.В., Дичева Д.Т., Андреев Д.Н. Возможности применения домперидона в комплексной терапии гастроэзофагеальной рефлюксной болезни. Медицинский совет, 2012, 2: 56-60Maev IV, Dicheva DT, Andreev DN. Possibilities of using domperidone in the complex therapy of gastroesophageal reflux disease. Meditsinskiy sovet, 2012, 2: 56-60.Маев И.В., Самсонов А.А., Андреев Д.Н. Клиническое значение синдрома «перекреста» функциональной диспепсии и гастроэзофагеальной рефлюксной болезни. Клинические перспективы гастроэнтерологии, гепатологии, 2013, 5: 17-22Maev IV, Samsonov AA, Andreev DN. Clinical significance of the syndrome of «cross» of functional dyspepsia and gastro-esophageal reflux disease. Klinicheskie perspektivy gastroenterologii, gepatologii, 2013, 5: 17-22.van Noord C, Dieleman JP, van Herpen G et al. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands. Drug Saf, 2010, 33(11): 1003-14.van Noord C, Dieleman JP, van Herpen G et al. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands. Drug Saf, 2010, 33(11): 1003-14.Huang X, Lv B, Zhang S et al. Itopride therapy for functional dyspepsia: a meta-analysis. World J Gastroenterol, 2012, 18(48): 7371-7.Huang X, Lv B, Zhang S et al. Itopride therapy for functional dyspepsia: a meta-analysis. World J Gastroenterol, 2012, 18(48): 7371-7.Ford AC, Luthra P, Tack J et al. Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis. Gut, 2017, 66(3): 411-420.Ford AC, Luthra P, Tack J et al. Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis. Gut, 2017, 66(3): 411-420.

The authors declare that there are no conflicts of interest present.